Advances in Tumor Microenvironment and Immunotherapeutic Strategies for Hepatocellular Carcinoma
Open Access
- 1 January 2025
- journal article
- review article
- Published by Tech Science Press in Oncology Research
- Vol. 33 (9) , 2309-2329
Abstract
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy, largely driven by an immunosuppressive tumor microenvironment (TME) that facilitates tumor growth, immune escape, and resistance to therapy. Although immunothe... | Find, read and cite all the research you need on Tech Science PressKeywords
This publication has 108 references indexed in Scilit:
- Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapyMedcomm, 2024
- Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted TherapiesHepatology, 2020
- Therapeutic modulators of hepatic stellate cells for hepatocellular carcinomaInternational Journal of Cancer, 2020
- Crosstalk between cancer and immune cells: Role of tumor‐associated macrophages in the tumor microenvironmentCancer Medicine, 2019
- Cancer-associated fibroblasts promote the stemness of CD24+ liver cells via paracrine signalingJournal of Molecular Medicine, 2018
- Targeting Immune Checkpoints in Cancer TherapyJAMA, 2017
- Treg(s) in Cancer: Friends or Foe?Journal of Cellular Physiology, 2015
- Myeloid cells in hepatocellular carcinomaHepatology, 2015
- The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularizationHepatology, 2008
- Multidrug resistance–associated proteins are crucial for the viability of activated rat hepatic stellate cells†‡Hepatology, 2008